Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07811895
NA
Dual GIP/GLP-1 Receptor Agonist in Obese Women Before Frozen Embryo Transfer
Sponsor: RenJi Hospital
View on ClinicalTrials.gov
Summary
To evaluate the efficacy and safety of Dual GIP/GLP-1 receptor agonist pretreatment on reproductive outcomes in obese women before frozen embryo transfer.
Official title: Dual Glucose-dependent Insulinotropic Peptide (GIP) and Glucagon-like Peptide-1 (GLP-1) Receptor Agonist in Women With Obesity for Frozen Embryo Transfer (FET): Pragmatic, Multicenter, Randomized Controlled Trial
Key Details
Gender
FEMALE
Age Range
20 Years - 40 Years
Study Type
INTERVENTIONAL
Enrollment
1510
Start Date
2026-09
Completion Date
2030-12
Last Updated
2026-09-10
Healthy Volunteers
No
Conditions
Interventions
DRUG
Dual GIP/GLP-1 receptor agonist
16 weeks treatment
Locations (1)
RenJi Hospital
Shanghai, Shanghai Municipality, China